10:13 AM EDT, 07/31/2026 (MT Newswires) -- Nexstim (NXTMH.HE) secured an additional order for its NBS 6 therapy system from an existing Finnish private healthcare client. The transaction is part of the customer's expansion of its services, the medical technology company said Friday. The NBS 6 is used to treat major depression and chronic neuropathic pain.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.